AQR Capital Management
AKCA

AQR Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

AQR Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,387
Closed -$261K – 2311
2020
Q3 		$261K Buy
+14,387
New +$204K ﹤0.01% 1970
2019
Q3 		– Sell
-22,034
Closed -$517K – 2211
2019
Q2 		$517K Sell
22,034
-2,471
-10% -$61K ﹤0.01% 1722
2019
Q1 		$694K Buy
24,505
+2,657
+12% +$77.4K ﹤0.01% 1687
2018
Q4 		$658K Buy
+21,848
New +$612K ﹤0.01% 1669

AQR Capital Management's AKCA Position: Q4 2020 in Review

AQR Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 14,387 shares — an estimated $261K sold.

AQR Capital Management first reported a position in AKCA in Q4 2018 and held it in 4 quarters. The position peaked at $694K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • AQR Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • AQR Capital Management sold 14,387 Akcea Therapeutics Inc shares in Q4 2020, an estimated $261K.
  • AQR Capital Management first reported a position in Akcea Therapeutics Inc in Q4 2018 and held it in 4 quarters.
  • AQR Capital Management's Akcea Therapeutics Inc position peaked at $694K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.